Who are Agenus Inc.'s main suppliers?

Agenus Inc. (AGEN) key suppliers include: Ligand Pharmaceuticals Incorporated, Ligand Pharmaceuticals Incorporated, LIGAND, MINK-THERAPEUTICS-INC. View the full supplier network at chainsifter.com/chain/AGEN.

Who are Agenus Inc.'s major customers?

Agenus Inc. (AGEN) key customers include: ZYNEXT-VENTURES-USA-LLC. View the full customer network at chainsifter.com/chain/AGEN.

What sector is Agenus Inc. in?

Agenus Inc. (AGEN) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

AGEN Supply Chain: Agenus Inc. Supplier List & 8 Relationships

4Suppliers

1Customers

3Debt Items

20Related Chains

Agenus Inc. Suppliers

Ticker	Name	Confidence	Evidence
LGND	Ligand Pharmaceuticals Incorporated	90%	The Amendment Agreement provides for a release by Ligand of liens it has on certain of the Company's assets in exchange for a modification of the exercise price under the warrant
LGND	Ligand Pharmaceuticals Incorporated	90%	Reciprocal relationship from LGND graph: Reciprocal relationship from AGEN graph: The Amendment Agreement provides for a release by Ligand of liens it has on certain of the Company's assets in exchan…
LIGAND	LIGAND	90%	To determine the amortization of the recorded liability, we are required to estimate the total amount of future payments that Ligand is entitled to under the Ligand Purchase Agreement.
MINK-THERAPEUTICS-INC	MINK-THERAPEUTICS-INC	75%	We continue to have involvement with MiNK, including providing services under an Amended and Restated Intercompany Services Agreement

Agenus Inc. Customers

Ticker	Name	Confidence	Evidence
ZYNEXT-VENTURES-USA-LLC	ZYNEXT-VENTURES-USA-LLC	85%	we accounted for the transaction under ASC 610‑20, Other Income—Gains and Losses from the Derecognition of Nonfinancial Assets. We recognized a $ 40.4 million gain on Zydus asset sale in our Condense…

Agenus Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
AGEN-DEBT	Debt stack $41.1M	90%	Market cache reports total debt of $41.1M.
AGEN-DEBT-7569	Warrants outstanding: 675000	90%	xbrl warrant detail from xbrl 2022-11-30.
AGEN-DEBT-7570	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2021-12-31.

Agenus Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Agenus Inc..

Agenus Inc. Ownership

Holder	Name	Confidence	Evidence
AGEN-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC	VANGUARD CAPITAL MANAGEMENT LLC	90%	13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 90 tracked holders.

Agenus Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops
AURA	Aura Biosciences, Inc.	100.00	2
VEEV	Veeva Systems Inc.	100.00	2
TLSA	Tiziana Life Sciences Ltd	100.00	2
VKTX	Viking Therapeutics, Inc.	100.00	2
AVIR	Atea Pharmaceuticals, Inc.	100.00	2
CRIS	Curis, Inc.	100.00	2
WHWK	Whitehawk Therapeutics, Inc.	100.00	2
CABA	Cabaletta Bio, Inc.	100.00	2
CAH	Cardinal Health, Inc.	100.00	2
CPMV	Mosaic ImmunoEngineering, Inc.	100.00	2
CHRS	Coherus Oncology, Inc.	100.00	2
EDIT	Editas Medicine, Inc.	100.00	2
ANL	Adlai Nortye Ltd.	100.00	2
CLLS	Cellectis S.A.	100.00	2
BEAM	Beam Therapeutics Inc.	100.00	2
SDGR	Schrödinger, Inc.	100.00	2
CTMX	CytomX Therapeutics, Inc.	100.00	2
CRMD	CorMedix Inc.	100.00	2
EMMA	Emmaus Life Sciences, Inc.	100.00	2
GDTC	CytoMed Therapeutics Limited	100.00	2

Agenus Inc. Supply Chain